Bright Minds Biosciences annual total assets
2020
2021
2022
2023
2024
2025
Bright Minds Biosciences Total Assets Growth & History (DRUG)
Bright Minds Biosciences's total assets was $84.4M for fiscal 2025.
View full Bright Minds Biosciences company overviewBright Minds Biosciences annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $84.4M | $78.3M | +1282.92% |
| 2024 | 2024-09-30 | $6.1M | −$774,470 | −11.26% |
| 2023 | 2023-09-30 | $6.9M | −$5.2M | −43.09% |
| 2022 | 2022-09-30 | $12.1M | −$8.0M | −39.69% |
| 2021 | 2021-09-30 | $20.0M | $19.2M | +2176.76% |
| 2020 | 2020-09-30 | $880,216 | — | — |
Bright Minds Biosciences quarterly total assets
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | $310.3M | $257.8M | +491.14% |
| Q2 2026 | 2026-03-31 | $312.4M | $255.9M | +453.16% |
| Q1 2026 | 2025-12-31 | $90.9M | — | — |
| Q4 2025 | 2025-09-30 | $84.4M | $78.3M | +1282.92% |
| Q3 2025 | 2025-06-30 | $52.5M | — | — |
| Q2 2025 | 2025-03-31 | $56.5M | — | — |
| Q4 2024 | 2024-09-30 | $6.1M | −$774,470 | −11.26% |
| Q4 2023 | 2023-09-30 | $6.9M | −$5.2M | −43.09% |
| Q4 2022 | 2022-09-30 | $12.1M | −$8.0M | −39.69% |
| Q4 2021 | 2021-09-30 | $20.0M | $19.2M | +2176.76% |
| Q4 2020 | 2020-09-30 | $880,216 | — | — |
Bright Minds Biosciences total assets trends
Over the last five fiscal years, Bright Minds Biosciences's total assets increased from $880,216 to $84.4M, a change of $83.5M. The latest reported quarter, Q3 2026, shows $310.3M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bright Minds Biosciences source filings ↗